Literature DB >> 9345500

Functional basis of memory impairment in multiple sclerosis: a[18F]FDG PET study.

E Paulesu1, D Perani, F Fazio, G Comi, C Pozzilli, V Martinelli, M Filippi, V Bettinardi, G Sirabian, D Passafiume, A Anzini, G L Lenzi, N Canal, C Fieschi.   

Abstract

Structural neuroimaging has been used to correlate lesional patterns with the cognitive profile of patients with multiple sclerosis (MS), especially for "frontal" dysfunction. However, a clear-cut anatomical explanation has yet to be found for the long-term memory deficit which is a hallmark of MS cognitive impairment. We have used PET to measure regional cerebral glucose metabolism (rCMRglc) in a group of 15 MS patients with involvement of verbal and/or spatial long-term memory. These patients were compared with 10 normal controls and 13 MS patients unimpaired on all neuropsychological tests. Relative to the controls, MS patients with memory deficits showed a significant bilateral reduction of rCMRglc in the hippocampus, cingulate gyrus, thalamus, associative occipital cortex, and cerebellum. Direct comparisons between patients with memory deficits and the group of unimpaired MS patients showed a metabolic reduction in the left thalamus and in both hippocampi. Seven of the memory-impaired patients also had neuropsychological signs of frontal dysfunction. These patients were compared with patients who had isolated memory deficit. Here we observed a further metabolic reduction in a number of brain regions including bilateral prefrontal cortex, inferior parietal cortex, and basal ganglia. Our findings indicate that hypometabolism of thalamic and deep cortical gray structures of the temporal lobe is associated with episodic memory dysfunction in MS. On the other hand, pathological performance on tests designed to assess frontal functions was associated with widespread reduction of glucose metabolism.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9345500     DOI: 10.1006/nimg.1996.0032

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  35 in total

1.  Metabolic disturbances in the gray matter of the human brain in autoimmune demyelinating disease of the nervous system and their contribution to the symptomatology of the disease.

Authors:  L N Prakhova; A G Il'ves; G V Kataeva; M S Rudas; N A Totolyan; I D Stolyarov
Journal:  Dokl Biol Sci       Date:  2002 Sep-Oct

Review 2.  The Role of Advanced Magnetic Resonance Imaging Techniques in Multiple Sclerosis Clinical Trials.

Authors:  Kedar R Mahajan; Daniel Ontaneda
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

3.  Electrophysiological evidence for a defect in the processing of temporal sound patterns in multiple sclerosis.

Authors:  S J Jones; L Sprague; M Vaz Pato
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-11       Impact factor: 10.154

Review 4.  Positron emission tomography imaging in neurological disorders.

Authors:  Marios Politis; Paola Piccini
Journal:  J Neurol       Date:  2012-09       Impact factor: 4.849

5.  White matter rather than gray matter damage characterizes essential tremor.

Authors:  Sara Pietracupa; Matteo Bologna; Komal Bharti; Gabriele Pasqua; Silvia Tommasin; Francesca Elifani; Giulia Paparella; Nikolaos Petsas; Giovanni Grillea; Alfredo Berardelli; Patrizia Pantano
Journal:  Eur Radiol       Date:  2019-05-28       Impact factor: 5.315

6.  Lyme disease of the brainstem.

Authors:  Peter Kalina; Andrew Decker; Ezriel Kornel; John J Halperin
Journal:  Neuroradiology       Date:  2005-09-13       Impact factor: 2.804

7.  A multiparametric evaluation of regional brain damage in patients with primary progressive multiple sclerosis.

Authors:  Antonia Ceccarelli; Maria A Rocca; Paola Valsasina; Mariaemma Rodegher; Elisabetta Pagani; Andrea Falini; Giancarlo Comi; Massimo Filippi
Journal:  Hum Brain Mapp       Date:  2009-09       Impact factor: 5.038

Review 8.  Imaging as an Outcome Measure in Multiple Sclerosis.

Authors:  Daniel Ontaneda; Robert J Fox
Journal:  Neurotherapeutics       Date:  2017-01       Impact factor: 7.620

9.  Perfusion magnetic resonance imaging correlates of neuropsychological impairment in multiple sclerosis.

Authors:  Matilde Inglese; Sumita Adhya; Glyn Johnson; James S Babb; Laura Miles; Hina Jaggi; Joseph Herbert; Robert I Grossman
Journal:  J Cereb Blood Flow Metab       Date:  2007-05-02       Impact factor: 6.200

10.  Short-latency afferent inhibition predicts verbal memory performance in patients with multiple sclerosis.

Authors:  Laura Cucurachi; Paolo Immovilli; Franco Granella; Giovanni Pavesi; Luigi Cattaneo
Journal:  J Neurol       Date:  2008-10-07       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.